Our finding on the one hand questions the non-response to chemotherapy theory and on the other hand asks for further elucidation of the precise prognostic role of CD133 as an important prognostic factor for considering adjuvant therapy in stage II and III colon cancer. The gene discussed is PROM1; the disease is malignant colon neoplasm.